IHAM

Integral Health Asset Management Portfolio holdings

AUM $1.07B
This Quarter Return
+20.34%
1 Year Return
+40.53%
3 Year Return
+328.04%
5 Year Return
+535.34%
10 Year Return
AUM
$693M
AUM Growth
+$693M
Cap. Flow
-$91.4M
Cap. Flow %
-13.2%
Top 10 Hldgs %
31.56%
Holding
95
New
31
Increased
14
Reduced
20
Closed
26

Top Sells

1
CYTK icon
Cytokinetics
CYTK
$50.1M
2
ARGX icon
argenx
ARGX
$34.4M
3
MCK icon
McKesson
MCK
$21.7M
4
AMGN icon
Amgen
AMGN
$17.5M
5
CI icon
Cigna
CI
$17.2M

Sector Composition

1 Healthcare 100%
2 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
WBA
1
DELISTED
Walgreens Boots Alliance
WBA
$28.7M 3.91% 1,100,000 +850,000 +340% +$22.2M
THC icon
2
Tenet Healthcare
THC
$16.3B
$26.4M 3.6% 350,000 -190,000 -35% -$14.4M
ABBV icon
3
AbbVie
ABBV
$372B
$26.3M 3.59% +170,000 New +$26.3M
NVS icon
4
Novartis
NVS
$245B
$22.7M 3.09% 225,000 +25,000 +13% +$2.52M
REGN icon
5
Regeneron Pharmaceuticals
REGN
$61.5B
$22M 2.99% +25,000 New +$22M
BSX icon
6
Boston Scientific
BSX
$156B
$21.7M 2.95% 375,000 -175,000 -32% -$10.1M
SNY icon
7
Sanofi
SNY
$121B
$19.9M 2.71% +400,000 New +$19.9M
TFX icon
8
Teleflex
TFX
$5.59B
$17.5M 2.38% +70,000 New +$17.5M
CYTK icon
9
Cytokinetics
CYTK
$4.23B
$16.7M 2.27% 200,000 -600,000 -75% -$50.1M
EHC icon
10
Encompass Health
EHC
$12.3B
$16.7M 2.27% 250,000
LLY icon
11
Eli Lilly
LLY
$657B
$16.3M 2.22% 28,000 +3,000 +12% +$1.75M
DXCM icon
12
DexCom
DXCM
$29.5B
$15.5M 2.11% 125,000 -50,000 -29% -$6.2M
CRL icon
13
Charles River Laboratories
CRL
$8.04B
$15.4M 2.09% +65,000 New +$15.4M
COR icon
14
Cencora
COR
$56.5B
$14.4M 1.96% 70,000 -40,000 -36% -$8.22M
NTRA icon
15
Natera
NTRA
$23.1B
$14.1M 1.92% 225,000 +25,000 +13% +$1.57M
ISRG icon
16
Intuitive Surgical
ISRG
$170B
$13.5M 1.84% +40,000 New +$13.5M
MLTX icon
17
MoonLake Immunotherapeutics
MLTX
$3.54B
$13.3M 1.81% 220,000 -280,000 -56% -$16.9M
COO icon
18
Cooper Companies
COO
$13.4B
$13.2M 1.8% 35,000 +20,000 +133% +$7.57M
BPMC
19
DELISTED
Blueprint Medicines
BPMC
$12.9M 1.76% 140,000 +90,000 +180% +$8.3M
ITCI
20
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$12.5M 1.71% 175,000 +42,000 +32% +$3.01M
INSP icon
21
Inspire Medical Systems
INSP
$2.77B
$12.2M 1.66% 60,000 -45,000 -43% -$9.15M
ZBH icon
22
Zimmer Biomet
ZBH
$21B
$12.2M 1.66% 100,000 +30,000 +43% +$3.65M
NBIX icon
23
Neurocrine Biosciences
NBIX
$13.8B
$11.9M 1.62% 90,000 +5,000 +6% +$659K
CABA icon
24
Cabaletta Bio
CABA
$133M
$11.8M 1.61% 520,000 +190,000 +58% +$4.31M
LH icon
25
Labcorp
LH
$23.1B
$11.4M 1.55% +50,000 New +$11.4M